The new technology start-up said it planned to use the funding to scale up manufacturing of its mall nanopore-based molecular sensing device
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
Globally, rising R&D expenditures and rising number of research activities has increased the demand for bioinformatics in the market
Forming global alliances and strategic partnerships with biopharma groups and others in an effort to accelerate oncology and immune-oncology trials
NGS has triggered a tidal wave of genomic data, whose footprint has rapidly expanded beyond the capacity of our existing storage. In partnership with data optimisation and compression experts Geneformics, we will explore the challenges and opportunities of these giant datasets